Effect of rHuG-CSF on Routine Hematological Parameters
| . | T0 . | T1 . | P<* . | T2 . | P<* . | T3 . | P<* . |
|---|---|---|---|---|---|---|---|
| WBC (×109/L) | 5.9 (4.3-10.3) | 28.35 (16.3-42.0) | .01 | 44.36 (22.6-74.63) | .01 | 4.8 (2.92-11.4) | NS |
| PMN (×109/L) | 3.1 (1.9-6.3) | 23.1 (13.4-33.2) | .01 | 37.6 (17.1-67) | .01 | 2.8 (1-6.6) | NS |
| Monocytes (×109/L) | 0.4 (0.1-1.0) | 1.2 (0.6-5.6) | .01 | 2.3 (1.2-6.0) | .01 | 0.2 (0.1-2.0) | NS |
| Hematocrit (%) | 42 (33.8-45.7) | 40.1 (33.5-47.0) | NS | 41.4 (34.3-48.0) | NS | 38.4 (30.3-48.1) | .01 |
| Hemoglobin (g/L) | 14.1 (11.5-16) | 14 (11.7-16.6) | NS | 13.8 (11.1-16.5) | NS | 13.0 (10.7-16.8) | .01 |
| RBC (×1012/L) | 4.72 (3.7-5.3) | 4.68 (3.99-5.22) | NS | 4.63 (3.66-5.25) | NS | 4.39 (3.41-5.5) | .01 |
| Platelets (×109/L) | 218 (146-296) | 205 (129-279) | NS | 199 (98-341) | NS | 189 (114-344) | .05 |
| . | T0 . | T1 . | P<* . | T2 . | P<* . | T3 . | P<* . |
|---|---|---|---|---|---|---|---|
| WBC (×109/L) | 5.9 (4.3-10.3) | 28.35 (16.3-42.0) | .01 | 44.36 (22.6-74.63) | .01 | 4.8 (2.92-11.4) | NS |
| PMN (×109/L) | 3.1 (1.9-6.3) | 23.1 (13.4-33.2) | .01 | 37.6 (17.1-67) | .01 | 2.8 (1-6.6) | NS |
| Monocytes (×109/L) | 0.4 (0.1-1.0) | 1.2 (0.6-5.6) | .01 | 2.3 (1.2-6.0) | .01 | 0.2 (0.1-2.0) | NS |
| Hematocrit (%) | 42 (33.8-45.7) | 40.1 (33.5-47.0) | NS | 41.4 (34.3-48.0) | NS | 38.4 (30.3-48.1) | .01 |
| Hemoglobin (g/L) | 14.1 (11.5-16) | 14 (11.7-16.6) | NS | 13.8 (11.1-16.5) | NS | 13.0 (10.7-16.8) | .01 |
| RBC (×1012/L) | 4.72 (3.7-5.3) | 4.68 (3.99-5.22) | NS | 4.63 (3.66-5.25) | NS | 4.39 (3.41-5.5) | .01 |
| Platelets (×109/L) | 218 (146-296) | 205 (129-279) | NS | 199 (98-341) | NS | 189 (114-344) | .05 |
Abbreviation: NS, not significant.
Anova one-way analysis of variance test.